Principle Wealth Partners LLC Syndax Pharmaceuticals Inc Transaction History

Principle Wealth Partners LLC

  • $1.33 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023
BUY
$20.64 - $26.24 $309,600 - $393,600
15,000 New
15,000 $381,000
Q2 2022

Aug 02, 2022
SELL
$13.64 - $19.48 $88,660 - $126,620
-6,500 Reduced 31.71%
14,000 $269,000
Q4 2020

Feb 16, 2021
BUY
$15.1 - $26.44 $309,550 - $542,020
20,500 New
20,500 $456,000

Others Institutions Holding SNDX

# of Institutions
230
Shares Held
90M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Principle Wealth Partners LLC Portfolio

Follow Principle Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principle Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principle Wealth Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email